Loading…

Predictive factors to estimate the severity of nonalcoholic fatty liver disease in candidates for Roux-en-Y gastric bypass

•Hyperferritinemia was higher in individuals with severe non-alcoholic fatty liver disease.•An increase of 1 ng/mL in vitamin D level may reduce severe steatosis by 10%.•An increase of 1 U/L of alanine aminotransferase increases the chances of severe steatosis by 13%.•Predictive factors of severe no...

Full description

Saved in:
Bibliographic Details
Published in:Nutrition (Burbank, Los Angeles County, Calif.) Los Angeles County, Calif.), 2023-12, Vol.116, p.112190-112190, Article 112190
Main Authors: Gebara, Telma Souza e Silva, Felicidade, Ingrid, Costa, Giselle Nobre, de Ramos, Marilia Zaparolli, Bonde, Ana Carolina, Palermo, Giovani, Guemra, Samuel, Peres, José Henrique de Souza, Mantovani, Mário Sérgio, Napoli, Rodrigo Picheth Di, Campos, Antônio Carlos Ligocki
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c310t-a3fabc7b688f8289edf24af831e8f7cfa01fd9c31ce08d1fa5dfd97ee991aa7a3
container_end_page 112190
container_issue
container_start_page 112190
container_title Nutrition (Burbank, Los Angeles County, Calif.)
container_volume 116
creator Gebara, Telma Souza e Silva
Felicidade, Ingrid
Costa, Giselle Nobre
de Ramos, Marilia Zaparolli
Bonde, Ana Carolina
Palermo, Giovani
Guemra, Samuel
Peres, José Henrique de Souza
Mantovani, Mário Sérgio
Napoli, Rodrigo Picheth Di
Campos, Antônio Carlos Ligocki
description •Hyperferritinemia was higher in individuals with severe non-alcoholic fatty liver disease.•An increase of 1 ng/mL in vitamin D level may reduce severe steatosis by 10%.•An increase of 1 U/L of alanine aminotransferase increases the chances of severe steatosis by 13%.•Predictive factors of severe non-alcoholic fatty liver disease improve monitoring of patients who are obese. Non-alcoholic fatty liver disease (NAFLD) is related to obesity, insulin resistance, dyslipidemia, and metabolic syndrome. The increasing prevalence of NAFLD results in a significant number of patients manifesting chronic liver disease over time. The aim of this study was to analyze the predictive factors to estimate NAFLD severity in patients who are candidates for Roux-en-Y gastric bypass. This descriptive observational study was conducted with 136 obese patients who were candidates for Roux-en-Y gastric bypass and had mild, moderate, or severe NAFLD. Severe NAFLD was more prevalent among the men (P = 0.007), and mild NAFLD was more prevalent among the women (P = 0.007). Hyperferritinemia was observed in the group with severe NAFLD (P = 0.01). Neck circumference and waist-to-height ratio were associated with an increased risk when comparing the groups with mild and severe NAFLD and those with moderate and severe NAFLD (P = 0.023 and P = 0.001, respectively); the alanine aminotransferase (ALT) and aspartate aminotransferase ratio values were >1 (P = 0.002) in the same comparisons. The regression analyses showed that an increase of 1 ng/mL in vitamin D reduced the chances of severe steatosis by 10% (P = 0.043), and an increase of 1 U/L ALT increased the chances of severe steatosis by 13% (P = 0.002). High neck circumference and low waist-to-height ratio values, male sex, hyperferritinemia, increased serum ALT values, and decreased vitamin D levels were related to the risk for severe NAFLD.
doi_str_mv 10.1016/j.nut.2023.112190
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2868124112</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0899900723002186</els_id><sourcerecordid>2868124112</sourcerecordid><originalsourceid>FETCH-LOGICAL-c310t-a3fabc7b688f8289edf24af831e8f7cfa01fd9c31ce08d1fa5dfd97ee991aa7a3</originalsourceid><addsrcrecordid>eNp9kcFqGzEURUVpoG7SD-hO0E024-rNuDMSWZWQNIFAS0kWWQlZempkJiNHT2Pifn2fcVdddCUkzhHce4X4CGoJCvrPm-U012Wr2m4J0IJRb8QC9NA10K5Wb8VCaWMao9TwTrwn2iilwPRmIX7_KBiSr2mHMjpfcyFZs0Sq6dlVlPUJJeEOS6p7maOc8uRGn5_ymDwLlV9HdosMidARyjRJ76aQAtskYy7yZ55fG5yaR_nLUS3srfdbR3QmTqIbCT_8PU_Fw_XV_eVNc_f92-3l17vGd6Bq47ro1n5Y91pH3WqDIbYrF3UHqOPgo1MQg2HWo9IBovsS-D4gGgPODa47FefHf7clv8yczD4n8jiObsI8k211r7klro3RT_-gmzwXTnygtFH9sBqAKThSvmSigtFuC7dV9haUPaxhN5bXsIc17HENdi6ODnLSXcJiySecPJdf0FcbcvqP_QdZlZVb</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2889067471</pqid></control><display><type>article</type><title>Predictive factors to estimate the severity of nonalcoholic fatty liver disease in candidates for Roux-en-Y gastric bypass</title><source>ScienceDirect Journals</source><creator>Gebara, Telma Souza e Silva ; Felicidade, Ingrid ; Costa, Giselle Nobre ; de Ramos, Marilia Zaparolli ; Bonde, Ana Carolina ; Palermo, Giovani ; Guemra, Samuel ; Peres, José Henrique de Souza ; Mantovani, Mário Sérgio ; Napoli, Rodrigo Picheth Di ; Campos, Antônio Carlos Ligocki</creator><creatorcontrib>Gebara, Telma Souza e Silva ; Felicidade, Ingrid ; Costa, Giselle Nobre ; de Ramos, Marilia Zaparolli ; Bonde, Ana Carolina ; Palermo, Giovani ; Guemra, Samuel ; Peres, José Henrique de Souza ; Mantovani, Mário Sérgio ; Napoli, Rodrigo Picheth Di ; Campos, Antônio Carlos Ligocki</creatorcontrib><description>•Hyperferritinemia was higher in individuals with severe non-alcoholic fatty liver disease.•An increase of 1 ng/mL in vitamin D level may reduce severe steatosis by 10%.•An increase of 1 U/L of alanine aminotransferase increases the chances of severe steatosis by 13%.•Predictive factors of severe non-alcoholic fatty liver disease improve monitoring of patients who are obese. Non-alcoholic fatty liver disease (NAFLD) is related to obesity, insulin resistance, dyslipidemia, and metabolic syndrome. The increasing prevalence of NAFLD results in a significant number of patients manifesting chronic liver disease over time. The aim of this study was to analyze the predictive factors to estimate NAFLD severity in patients who are candidates for Roux-en-Y gastric bypass. This descriptive observational study was conducted with 136 obese patients who were candidates for Roux-en-Y gastric bypass and had mild, moderate, or severe NAFLD. Severe NAFLD was more prevalent among the men (P = 0.007), and mild NAFLD was more prevalent among the women (P = 0.007). Hyperferritinemia was observed in the group with severe NAFLD (P = 0.01). Neck circumference and waist-to-height ratio were associated with an increased risk when comparing the groups with mild and severe NAFLD and those with moderate and severe NAFLD (P = 0.023 and P = 0.001, respectively); the alanine aminotransferase (ALT) and aspartate aminotransferase ratio values were &gt;1 (P = 0.002) in the same comparisons. The regression analyses showed that an increase of 1 ng/mL in vitamin D reduced the chances of severe steatosis by 10% (P = 0.043), and an increase of 1 U/L ALT increased the chances of severe steatosis by 13% (P = 0.002). High neck circumference and low waist-to-height ratio values, male sex, hyperferritinemia, increased serum ALT values, and decreased vitamin D levels were related to the risk for severe NAFLD.</description><identifier>ISSN: 0899-9007</identifier><identifier>EISSN: 1873-1244</identifier><identifier>DOI: 10.1016/j.nut.2023.112190</identifier><language>eng</language><publisher>Kidlington: Elsevier Inc</publisher><subject>Alanine ; Alanine transaminase ; Aminotransferases ; Aspartate aminotransferase ; Body fat ; Body mass index ; Calciferol ; Decision trees ; Developing countries ; Diabetes ; Dyslipidemia ; Fatty liver ; Gastric bypass ; Gastrointestinal surgery ; Glucose ; Hyperferritinemia ; Insulin ; Insulin resistance ; LDCs ; Liver ; Liver diseases ; Liver fibrosis ; Metabolic disorders ; Metabolic syndrome ; Metabolism ; Obesity ; Observational studies ; Regression analysis ; Sex ratio ; Steatosis ; Transaminases ; Ultrasonic imaging ; Vitamin D ; Women</subject><ispartof>Nutrition (Burbank, Los Angeles County, Calif.), 2023-12, Vol.116, p.112190-112190, Article 112190</ispartof><rights>2023 Elsevier Inc.</rights><rights>2023. Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c310t-a3fabc7b688f8289edf24af831e8f7cfa01fd9c31ce08d1fa5dfd97ee991aa7a3</cites><orcidid>0000-0002-6930-2299 ; 0000-0003-1938-6268 ; 0000-0001-6231-9445 ; 0000-0003-0211-7547</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,786,790,27957,27958</link.rule.ids></links><search><creatorcontrib>Gebara, Telma Souza e Silva</creatorcontrib><creatorcontrib>Felicidade, Ingrid</creatorcontrib><creatorcontrib>Costa, Giselle Nobre</creatorcontrib><creatorcontrib>de Ramos, Marilia Zaparolli</creatorcontrib><creatorcontrib>Bonde, Ana Carolina</creatorcontrib><creatorcontrib>Palermo, Giovani</creatorcontrib><creatorcontrib>Guemra, Samuel</creatorcontrib><creatorcontrib>Peres, José Henrique de Souza</creatorcontrib><creatorcontrib>Mantovani, Mário Sérgio</creatorcontrib><creatorcontrib>Napoli, Rodrigo Picheth Di</creatorcontrib><creatorcontrib>Campos, Antônio Carlos Ligocki</creatorcontrib><title>Predictive factors to estimate the severity of nonalcoholic fatty liver disease in candidates for Roux-en-Y gastric bypass</title><title>Nutrition (Burbank, Los Angeles County, Calif.)</title><description>•Hyperferritinemia was higher in individuals with severe non-alcoholic fatty liver disease.•An increase of 1 ng/mL in vitamin D level may reduce severe steatosis by 10%.•An increase of 1 U/L of alanine aminotransferase increases the chances of severe steatosis by 13%.•Predictive factors of severe non-alcoholic fatty liver disease improve monitoring of patients who are obese. Non-alcoholic fatty liver disease (NAFLD) is related to obesity, insulin resistance, dyslipidemia, and metabolic syndrome. The increasing prevalence of NAFLD results in a significant number of patients manifesting chronic liver disease over time. The aim of this study was to analyze the predictive factors to estimate NAFLD severity in patients who are candidates for Roux-en-Y gastric bypass. This descriptive observational study was conducted with 136 obese patients who were candidates for Roux-en-Y gastric bypass and had mild, moderate, or severe NAFLD. Severe NAFLD was more prevalent among the men (P = 0.007), and mild NAFLD was more prevalent among the women (P = 0.007). Hyperferritinemia was observed in the group with severe NAFLD (P = 0.01). Neck circumference and waist-to-height ratio were associated with an increased risk when comparing the groups with mild and severe NAFLD and those with moderate and severe NAFLD (P = 0.023 and P = 0.001, respectively); the alanine aminotransferase (ALT) and aspartate aminotransferase ratio values were &gt;1 (P = 0.002) in the same comparisons. The regression analyses showed that an increase of 1 ng/mL in vitamin D reduced the chances of severe steatosis by 10% (P = 0.043), and an increase of 1 U/L ALT increased the chances of severe steatosis by 13% (P = 0.002). High neck circumference and low waist-to-height ratio values, male sex, hyperferritinemia, increased serum ALT values, and decreased vitamin D levels were related to the risk for severe NAFLD.</description><subject>Alanine</subject><subject>Alanine transaminase</subject><subject>Aminotransferases</subject><subject>Aspartate aminotransferase</subject><subject>Body fat</subject><subject>Body mass index</subject><subject>Calciferol</subject><subject>Decision trees</subject><subject>Developing countries</subject><subject>Diabetes</subject><subject>Dyslipidemia</subject><subject>Fatty liver</subject><subject>Gastric bypass</subject><subject>Gastrointestinal surgery</subject><subject>Glucose</subject><subject>Hyperferritinemia</subject><subject>Insulin</subject><subject>Insulin resistance</subject><subject>LDCs</subject><subject>Liver</subject><subject>Liver diseases</subject><subject>Liver fibrosis</subject><subject>Metabolic disorders</subject><subject>Metabolic syndrome</subject><subject>Metabolism</subject><subject>Obesity</subject><subject>Observational studies</subject><subject>Regression analysis</subject><subject>Sex ratio</subject><subject>Steatosis</subject><subject>Transaminases</subject><subject>Ultrasonic imaging</subject><subject>Vitamin D</subject><subject>Women</subject><issn>0899-9007</issn><issn>1873-1244</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp9kcFqGzEURUVpoG7SD-hO0E024-rNuDMSWZWQNIFAS0kWWQlZempkJiNHT2Pifn2fcVdddCUkzhHce4X4CGoJCvrPm-U012Wr2m4J0IJRb8QC9NA10K5Wb8VCaWMao9TwTrwn2iilwPRmIX7_KBiSr2mHMjpfcyFZs0Sq6dlVlPUJJeEOS6p7maOc8uRGn5_ymDwLlV9HdosMidARyjRJ76aQAtskYy7yZ55fG5yaR_nLUS3srfdbR3QmTqIbCT_8PU_Fw_XV_eVNc_f92-3l17vGd6Bq47ro1n5Y91pH3WqDIbYrF3UHqOPgo1MQg2HWo9IBovsS-D4gGgPODa47FefHf7clv8yczD4n8jiObsI8k211r7klro3RT_-gmzwXTnygtFH9sBqAKThSvmSigtFuC7dV9haUPaxhN5bXsIc17HENdi6ODnLSXcJiySecPJdf0FcbcvqP_QdZlZVb</recordid><startdate>202312</startdate><enddate>202312</enddate><creator>Gebara, Telma Souza e Silva</creator><creator>Felicidade, Ingrid</creator><creator>Costa, Giselle Nobre</creator><creator>de Ramos, Marilia Zaparolli</creator><creator>Bonde, Ana Carolina</creator><creator>Palermo, Giovani</creator><creator>Guemra, Samuel</creator><creator>Peres, José Henrique de Souza</creator><creator>Mantovani, Mário Sérgio</creator><creator>Napoli, Rodrigo Picheth Di</creator><creator>Campos, Antônio Carlos Ligocki</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RQ</scope><scope>7RV</scope><scope>7TS</scope><scope>7U7</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-6930-2299</orcidid><orcidid>https://orcid.org/0000-0003-1938-6268</orcidid><orcidid>https://orcid.org/0000-0001-6231-9445</orcidid><orcidid>https://orcid.org/0000-0003-0211-7547</orcidid></search><sort><creationdate>202312</creationdate><title>Predictive factors to estimate the severity of nonalcoholic fatty liver disease in candidates for Roux-en-Y gastric bypass</title><author>Gebara, Telma Souza e Silva ; Felicidade, Ingrid ; Costa, Giselle Nobre ; de Ramos, Marilia Zaparolli ; Bonde, Ana Carolina ; Palermo, Giovani ; Guemra, Samuel ; Peres, José Henrique de Souza ; Mantovani, Mário Sérgio ; Napoli, Rodrigo Picheth Di ; Campos, Antônio Carlos Ligocki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c310t-a3fabc7b688f8289edf24af831e8f7cfa01fd9c31ce08d1fa5dfd97ee991aa7a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Alanine</topic><topic>Alanine transaminase</topic><topic>Aminotransferases</topic><topic>Aspartate aminotransferase</topic><topic>Body fat</topic><topic>Body mass index</topic><topic>Calciferol</topic><topic>Decision trees</topic><topic>Developing countries</topic><topic>Diabetes</topic><topic>Dyslipidemia</topic><topic>Fatty liver</topic><topic>Gastric bypass</topic><topic>Gastrointestinal surgery</topic><topic>Glucose</topic><topic>Hyperferritinemia</topic><topic>Insulin</topic><topic>Insulin resistance</topic><topic>LDCs</topic><topic>Liver</topic><topic>Liver diseases</topic><topic>Liver fibrosis</topic><topic>Metabolic disorders</topic><topic>Metabolic syndrome</topic><topic>Metabolism</topic><topic>Obesity</topic><topic>Observational studies</topic><topic>Regression analysis</topic><topic>Sex ratio</topic><topic>Steatosis</topic><topic>Transaminases</topic><topic>Ultrasonic imaging</topic><topic>Vitamin D</topic><topic>Women</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gebara, Telma Souza e Silva</creatorcontrib><creatorcontrib>Felicidade, Ingrid</creatorcontrib><creatorcontrib>Costa, Giselle Nobre</creatorcontrib><creatorcontrib>de Ramos, Marilia Zaparolli</creatorcontrib><creatorcontrib>Bonde, Ana Carolina</creatorcontrib><creatorcontrib>Palermo, Giovani</creatorcontrib><creatorcontrib>Guemra, Samuel</creatorcontrib><creatorcontrib>Peres, José Henrique de Souza</creatorcontrib><creatorcontrib>Mantovani, Mário Sérgio</creatorcontrib><creatorcontrib>Napoli, Rodrigo Picheth Di</creatorcontrib><creatorcontrib>Campos, Antônio Carlos Ligocki</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Career &amp; Technical Education Database</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Physical Education Index</collection><collection>Toxicology Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>British Nursing Database</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>British Nursing Index</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>PML(ProQuest Medical Library)</collection><collection>Research Library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Nutrition (Burbank, Los Angeles County, Calif.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gebara, Telma Souza e Silva</au><au>Felicidade, Ingrid</au><au>Costa, Giselle Nobre</au><au>de Ramos, Marilia Zaparolli</au><au>Bonde, Ana Carolina</au><au>Palermo, Giovani</au><au>Guemra, Samuel</au><au>Peres, José Henrique de Souza</au><au>Mantovani, Mário Sérgio</au><au>Napoli, Rodrigo Picheth Di</au><au>Campos, Antônio Carlos Ligocki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Predictive factors to estimate the severity of nonalcoholic fatty liver disease in candidates for Roux-en-Y gastric bypass</atitle><jtitle>Nutrition (Burbank, Los Angeles County, Calif.)</jtitle><date>2023-12</date><risdate>2023</risdate><volume>116</volume><spage>112190</spage><epage>112190</epage><pages>112190-112190</pages><artnum>112190</artnum><issn>0899-9007</issn><eissn>1873-1244</eissn><notes>ObjectType-Article-1</notes><notes>SourceType-Scholarly Journals-1</notes><notes>ObjectType-Feature-2</notes><notes>content type line 23</notes><notes>ObjectType-Undefined-3</notes><abstract>•Hyperferritinemia was higher in individuals with severe non-alcoholic fatty liver disease.•An increase of 1 ng/mL in vitamin D level may reduce severe steatosis by 10%.•An increase of 1 U/L of alanine aminotransferase increases the chances of severe steatosis by 13%.•Predictive factors of severe non-alcoholic fatty liver disease improve monitoring of patients who are obese. Non-alcoholic fatty liver disease (NAFLD) is related to obesity, insulin resistance, dyslipidemia, and metabolic syndrome. The increasing prevalence of NAFLD results in a significant number of patients manifesting chronic liver disease over time. The aim of this study was to analyze the predictive factors to estimate NAFLD severity in patients who are candidates for Roux-en-Y gastric bypass. This descriptive observational study was conducted with 136 obese patients who were candidates for Roux-en-Y gastric bypass and had mild, moderate, or severe NAFLD. Severe NAFLD was more prevalent among the men (P = 0.007), and mild NAFLD was more prevalent among the women (P = 0.007). Hyperferritinemia was observed in the group with severe NAFLD (P = 0.01). Neck circumference and waist-to-height ratio were associated with an increased risk when comparing the groups with mild and severe NAFLD and those with moderate and severe NAFLD (P = 0.023 and P = 0.001, respectively); the alanine aminotransferase (ALT) and aspartate aminotransferase ratio values were &gt;1 (P = 0.002) in the same comparisons. The regression analyses showed that an increase of 1 ng/mL in vitamin D reduced the chances of severe steatosis by 10% (P = 0.043), and an increase of 1 U/L ALT increased the chances of severe steatosis by 13% (P = 0.002). High neck circumference and low waist-to-height ratio values, male sex, hyperferritinemia, increased serum ALT values, and decreased vitamin D levels were related to the risk for severe NAFLD.</abstract><cop>Kidlington</cop><pub>Elsevier Inc</pub><doi>10.1016/j.nut.2023.112190</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-6930-2299</orcidid><orcidid>https://orcid.org/0000-0003-1938-6268</orcidid><orcidid>https://orcid.org/0000-0001-6231-9445</orcidid><orcidid>https://orcid.org/0000-0003-0211-7547</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0899-9007
ispartof Nutrition (Burbank, Los Angeles County, Calif.), 2023-12, Vol.116, p.112190-112190, Article 112190
issn 0899-9007
1873-1244
language eng
recordid cdi_proquest_miscellaneous_2868124112
source ScienceDirect Journals
subjects Alanine
Alanine transaminase
Aminotransferases
Aspartate aminotransferase
Body fat
Body mass index
Calciferol
Decision trees
Developing countries
Diabetes
Dyslipidemia
Fatty liver
Gastric bypass
Gastrointestinal surgery
Glucose
Hyperferritinemia
Insulin
Insulin resistance
LDCs
Liver
Liver diseases
Liver fibrosis
Metabolic disorders
Metabolic syndrome
Metabolism
Obesity
Observational studies
Regression analysis
Sex ratio
Steatosis
Transaminases
Ultrasonic imaging
Vitamin D
Women
title Predictive factors to estimate the severity of nonalcoholic fatty liver disease in candidates for Roux-en-Y gastric bypass
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-21T11%3A49%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Predictive%20factors%20to%20estimate%20the%20severity%20of%20nonalcoholic%20fatty%20liver%20disease%20in%20candidates%20for%20Roux-en-Y%20gastric%20bypass&rft.jtitle=Nutrition%20(Burbank,%20Los%20Angeles%20County,%20Calif.)&rft.au=Gebara,%20Telma%20Souza%20e%20Silva&rft.date=2023-12&rft.volume=116&rft.spage=112190&rft.epage=112190&rft.pages=112190-112190&rft.artnum=112190&rft.issn=0899-9007&rft.eissn=1873-1244&rft_id=info:doi/10.1016/j.nut.2023.112190&rft_dat=%3Cproquest_cross%3E2868124112%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c310t-a3fabc7b688f8289edf24af831e8f7cfa01fd9c31ce08d1fa5dfd97ee991aa7a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2889067471&rft_id=info:pmid/&rfr_iscdi=true